EcoDrugPlus

Synuclein Alpha

Ensembl ID : ENSLBEG00000018712
Gene Symbol: SNCA
3 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSLBEG00000002230
Gene Symbol: TACR1
3 Cross references
194 Possible Orthologues:

Tachykinin Receptor 1b

Ensembl ID : ENSLBEG00000009073
Gene Symbol: TACR1B
1 Cross references
193 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSLBEG00000008913
Gene Symbol: TACR2
3 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSLBEG00000021286
Gene Symbol: TACR3
3 Cross references
208 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSLBEG00000023746
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSLBEG00000009210
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSLBEG00000022001
Gene Symbol: TBXA2R
1 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSLBEG00000024882
Gene Symbol: TYMP
3 Cross references
166 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSLBEG00000002952
Gene Symbol: TYMP
2 Cross references
166 Possible Orthologues:

Thymidine Phosphorylase-Like

Ensembl ID : ENSLBEG00000024817
Gene Symbol: LOC110002742
3 Cross references
166 Possible Orthologues:

Thymidine Phosphorylase-Like

Ensembl ID : ENSLBEG00000024936
Gene Symbol: LOC110002739
3 Cross references
166 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).